We are live on ! Find out more
NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

78 hedge funds and large institutions have $60.2M invested in Navidea Biopharmaceuticals Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 18 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 18

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less funds holding

Funds holding: 81 → 78 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

52% less capital invested

Capital invested by funds: $126M → $60.2M (-$66M)

97% less call options, than puts

Call options by funds: $213K | Put options by funds: $8.2M

Holders
78
Holders Change
-3
Holders Change %
-3.7%
% of All Funds
2.05%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
28
Reduced
18
Closed
11
Calls
$213K
Puts
$8.2M
Net Calls
-$7.99M
Net Calls Change
+$5.71M

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$333K
2
Renaissance Technologies
Renaissance Technologies
New York
+$291K
3
BFA
BlackRock Fund Advisors
California
+$195K
4
VKH
Virtu KCG Holdings
New York
+$181K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$180K

Top Sellers

Rank Fund Capital Flow
1
PM
Platinum Management
New York
-$16.1M
2
EI
EAM Investors
California
-$1.85M
3
Jane Street
Jane Street
New York
-$713K
4
SEI Investments
SEI Investments
Pennsylvania
-$427K
5
Deutsche Bank
Deutsche Bank
Germany
-$237K
Name Holding Trade Value Shares
Change 		Change in
Stake
Creative Planning
26
Creative Planning
Kansas
$168K – – –
MLICM
27
Metropolitan Life Insurance Company (MetLife)
New York
$152K +$660 +19 +0.3%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$138K +$180K +5,172 New
VKH
29
Virtu KCG Holdings
New York
$138K +$181K +5,204 New
NFA
30
Nationwide Fund Advisors
Ohio
$130K +$3.89K +112 +2%
AIG
31
American International Group
New York
$120K -$278 -8 -0.2%
Royal Bank of Canada
32
Royal Bank of Canada
Ontario, Canada
$118K +$123K +3,535 +401%
VOYA Investment Management
33
VOYA Investment Management
Georgia
$111K – – –
CS
34
Credit Suisse
Switzerland
$110K +$58K +1,671 +68%
Millennium Management
35
Millennium Management
New York
$106K +$138K +3,968 New
SI
36
SII Investments
Wisconsin
$95K -$33.5K -965 -21%
T. Rowe Price Associates
37
T. Rowe Price Associates
Maryland
$94K +$695 +20 +0.6%
Wells Fargo
38
Wells Fargo
California
$91K -$5.14K -148 -4%
BA
39
BlackRock Advisors
Delaware
$88K -$60K -1,729 -34%
GWM
40
Greenwich Wealth Management
Connecticut
$87K – – –
State Board of Administration of Florida Retirement System
41
State Board of Administration of Florida Retirement System
Florida
$80K – – –
Deutsche Bank
42
Deutsche Bank
Germany
$68K -$237K -6,835 -73%
SW
43
SVB Wealth
Massachusetts
$62K – – –
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$62K +$17.2K +495 +27%
ARTA
45
A.R.T. Advisors
New York
$62K +$81.9K +2,359 New
AllianceBernstein
46
AllianceBernstein
Tennessee
$61K – – –
Citigroup
47
Citigroup
New York
$61K +$69.5K +2,000 +623%
SWP
48
Stratos Wealth Partners
Ohio
$57K – – –
Citadel Advisors
49
Citadel Advisors
Florida
$52K +$21.4K +616 +46%
Commonwealth Equity Services
50
Commonwealth Equity Services
Massachusetts
$46K -$1.74K -50 -3%
1
2
3 4

NAVB Hedge Fund Activity: Q4 2015 in Review

78 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Navidea Biopharmaceuticals Inc. (NAVB) for Q4 2015, worth a combined $60.2M — down 52% from $126M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of NAVB and 8 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 28 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $333K. The largest seller was Platinum Management, cutting an estimated $16.1M.

  • 78 institutional investors held Navidea Biopharmaceuticals Inc. (NAVB) as of Q4 2015, down from 81 in Q3 2015.
  • Funds reported $60.2M of Navidea Biopharmaceuticals Inc. stock for Q4 2015, down 52% quarter-over-quarter.
  • 8 funds opened new Navidea Biopharmaceuticals Inc. positions in Q4 2015 and 11 closed out, a net change of -3 holders.
  • The largest Navidea Biopharmaceuticals Inc. buyer in Q4 2015 was BlackRock Institutional Trust, an estimated $333K added.
  • The largest Navidea Biopharmaceuticals Inc. seller in Q4 2015 was Platinum Management, an estimated $16.1M sold.

Based on aggregated 13F filings for Q4 2015.